WEIGHT / STRENGTH / SKIN / SURVIVAL
Weight fell in people; muscle strength improved in mice
Studies measured weight, grip, skin changes, and patient deaths. The four peptides had different tests. A better test result doesn't always mean better health.
MOTS-c
MOTS-c mice moved better and drew sugar into muscle. Whether your muscles would improve still needs a human trial.
Check the mouse strength findings →
Retatrutide
People receiving retatrutide lost weight in treatment trials. Those tests don't settle whether your weight would stay down afterward.
See how much patients lost →
GHK-Cu
GHK-Cu research includes skin tests and mixed hair treatments. You can't give one ingredient all the credit when several were used.
See what skin and hair tests measured →
Thymosin Alpha-1
Deaths weren't clearly reduced in the largest infection trial. Earlier hopeful results give you a weaker answer.
Read why the survival result changed →What a study can tell you about your health
A mouse running farther doesn't prove you'll walk better. Your blood test can't measure whether your muscles grew stronger. Smoother skin doesn't establish a healthier heart either. You get an answer to the question actually tested.
Human treatment trials get closer to your own question. Researchers compare people receiving treatment with people receiving something else. You can then separate the drug's effects from unrelated changes. Even a fair test can't settle every future harm.
Research Peptide Fundamentals research peptides covers four different study subjects. These are MOTS-c, retatrutide, GHK-Cu, and thymosin alpha-1. You can read about each peptide's results and limits. None of those names means a treatment has proved itself.
Check the treated patients, then the change relevant to you. Find out what the people receiving comparison treatment experienced. Your answer also depends on how long testing lasted. You don't yet know whether those benefits last for years.
Which changes were seen in people, animals, and cells
Patients lost weight when they received retatrutide [10][11][12]. Researchers compared their results with patients receiving other treatments. Chance determined treatment, helping keep the patient groups alike. Whether your weight would stay down remains an open question.
Cell tests examined how cells cope with energy shortages [5][6]. MOTS-c moved to the part where DNA is kept. DNA contains the instructions cells use to make proteins. Researchers saw changes in instructions linked with energy and damage.
In mice, muscles drew more sugar from blood [1]. MOTS-c attached to an enzyme called casein kinase 2. Enzymes are proteins that help chemical changes inside your cells. Those tests didn't establish stronger muscles in people like you.
GHK-Cu studies examined skin, hair, and cells in dishes [13][14][15][17]. Cell tests checked which protein-making instructions the cells used. Other tests measured copper entering skin or counted hair. Several ingredients went into some hair treatments, so you can't separate their effects.
An earlier thymosin alpha-1 trial suggested fewer infection deaths [22]. The larger phase 3 trial didn't confirm that benefit [18]. That's a later stage of testing in people. That stronger result gives you less reason to expect benefit.
Why sharing the name peptide doesn't mean sharing benefits
Peptides are made from amino acids, the parts forming proteins. Those parts link together in different ways. The resulting peptides can do different jobs inside your body. You can't expect identical benefits from substances sharing that name.
MOTS-c is made using DNA in cells' energy-producing parts [3][5]. Cell tests examined changes when cells had too little fuel. Researchers studied how the cells adjusted, rather than human strength. Whether added MOTS-c helps your muscles still needs human testing.
Retatrutide mimics some effects of three hormones [8][9]. Hormones carry messages between body parts through your blood. GHK-Cu binds copper and has skin-repair research [13][16][17]. Thymosin alpha-1 has infection and cancer-treatment studies [19][21].
A bottle's research label doesn't check the contents for you. The label can't prove the bottle contains the named substance. Nor can that label show freedom from germs or impurities. You only have findings for the substance researchers tested.
Your skin forms a barrier against many substances. Applying something there differs from putting the substance into blood. Likewise, a result in mice leaves human effects untested. A benefit claim needs evidence for the use being claimed.
What makes a treatment comparison more useful to you
A human trial can answer more than a cell test. Cells in dishes don't have your aching muscles. Animals allow researchers to study organs and movement together. Those animal tests still can't establish your response to treatment.
You see a matching treatment without the test drug: placebo. That comparison helps you see changes beyond ordinary recovery or expectations. For mixtures, your question also needs each ingredient tested separately. Otherwise, you can't tell which ingredient made the difference.
Lower blood sugar doesn't necessarily mean you'll feel stronger. Name the change that matters to your daily life. Check whether the study actually measured that change. A brief trial leaves later health problems largely unanswered.
Watching patients may reveal two things changing together. That doesn't show whether one change caused the other. Assigning treatment by chance makes patient groups easier to compare. Reviews gather findings, but can't strengthen weak underlying tests.
The comparison brings the different results together for you. Each peptide page then explains its own tested changes. No single winner emerges across such different health questions. For each claim, you can check the actual health test.